Sulforaphane-mediated reduction of aflatoxin B1-N7-guanine in rat liver DNA: Impacts of strain and sex

Toxicological Sciences

Volumn 121, Issue 1, 2011, Pages 57-62

  Fiala, Jeannette L A ^a,b   Egner, Patricia A ^c   Wiriyachan, Nirachara ^d,e   Ruchirawat, Mathuros ^d   Kensler, Kevin H ^c   Wogan, Gerald N ^a,b   Groopman, John D ^c   Croy, Robert G ^a,b   Essigmann, John M ^a,b  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Toxicology and Management of Chemicals   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Aflatoxin B1; Chemoprevention; DNA adducts; Glutathione S Transferase; Liver cancer; Sulforaphane

Indexed keywords

AFLATOXIN B1; DNA; GLUTATHIONE TRANSFERASE; SULFORAPHANE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; ETHNIC DIFFERENCE; FEMALE; FISCHER 344 RAT; LIVER; LIVER CARCINOGENESIS; LIVER PROTECTION; MALE; NONHUMAN; RAT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT;

RATTUS;

EID: 79955410882     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr026     Document Type: Article

References (28)

1. Busby, W. F., and Wogan, G. N. (1984). Aflatoxins. In Chemical Carcinogens (C. D. Searle, Ed.), pp. 945-1136. American Chemical Society, Washington, DC.
2. Dinkova-Kostova, A. T., Holtzclaw, W. D., and Kensler, T. W. (2005). The role of Keap1 in cellular protective responses. Chem. Res. Toxicol. 18, 1779-1791.
3. Egner, P. A., Gange, S. J., Dolan, P. M., Groopman, J. D., Muñoz, A., and Kensler, T. W. (1995). Levels of aflatoxin-albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Carcinogenesis 16, 1769-1773.
4. Egner, P. A., Groopman, J. D., Wang, J. S., Kensler, T. W., and Friesen, M. D. (2006). Quantification of aflatoxin-B1-N7-Guanine in human urine by high- performance liquid chromatography and isotope dilution tandem mass spectrometry. Chem. Res. Toxicol. 19, 1191-1195.
5. Fahey, J. W., Haristoy, X., Dolan, P. M., Kensler, T. W., Scholtus, I., Stephenson, K. K., Talalay, P., and Lozniewski, A. (2002). Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc. Natl. Acad. Sci. U.S.A 99, 7610-7615.
6. Fahey, J. W., and Talalay, P. (1999). Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes. Food Chem. Toxicol. 37, 973-979.
7. Fahey, J. W., Zhang, Y., and Talalay, P. (1997). Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A 94, 10367-10372.
8. Fatemi, F., Allameh, A., Dadkhah, A., Forouzandeh, M., Kazemnejad, S., and Sharifi, R. (2006). Changes in hepatic cytosolic glutathione S-transferase activity and expression of its class-P during prenatal and postnatal period in rats treated with aflatoxin B1. Arch. Toxicol. 80, 572-579.
9. Groopman, J. D., Busby, W. F., and Wogan, G. N. (1980). Nuclear distribution of aflatoxin B1 and its interaction with histones in rat liver in vivo. Cancer Res. 40, 4343-4351.
10. Groopman, J. D., Croy, R. G., Jr., and Wogan, G. N. (1981). In vitro reactions of aflatoxin B1-adducted DNA. Proc. Natl. Acad. Sci. U.S.A 78, 5445-5449.
11. Groopman, J. D., DeMatos, P., Egner, P. A., Love-Hunt, A., and Kensler, T. W. (1992a). Molecular dosimetry of urinary aflatoxin-N 7-guanine and serum aflatoxin-albumin adducts predicts chemoprotection by 1,2-dithiole-3-thione in rats. Carcinogenesis 13, 101-106.
12. Groopman, J. D., Jackson, P. E., Turner, P., Wild, C. P., and Kensler, T. W. (2002). Validation of exposure and risk biomarkers: aflatoxin as a case study. In Progress in Nucleic Acid Research and Molecular Biology, pp. 307-318. CRC Press LLC, Boca Raton, FL.
13. Groopman, J. D., Kensler, T. W., and Wild, C. P. (2008). Protective interventions to prevent aflatoxin-induced carcinogenesis in developing countries. Annu. Rev. Public Health 29, 187-203.
14. Groopman, J. D., Roebuck, B. D., Kensler, T. W., and D'Amato, R. (1992b). Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. In Relevance of Animal Studies to the Evaluation of Human Cancer Risk: Proceedings of a Symposium held December 5-8, 1990 in Austin, Texas, pp. 139-155. Wiley-Liss, Inc, New York, NY.
15. Gross-Steinmeyer, K., Stapleton, P. L., Tracy, J. H., Bammler, T. K., Strom, S. C., and Eaton, D. L. (2010). Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol. Sci. 116, 422-432.
16. Gurtoo, H. L., and Motycka, L. (1976). Effect of sex difference on the in vitro and in vivo metabolism of aflatoxin B1 by the rat. Cancer Res. 36, 4663-4671.
17. Habig, W. H., Pabst, M. J., and Jakoby, W. B. (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139.
18. Harris, A. J., Shaddock, J. G., Manjanatha, M. G., Lisenbey, J. A., and Casciano, D. A. (1998). Identification of differentially expressed genes in aflatoxin B1-treated cultured primary rat hepatocytes and Fischer 344 rats. Carcinogenesis 19, 1451-1458.
19. Kensler, T. W., Chen, J. G., Egner, P. A., Fahey, J. W., Jacobson, L. P., Stephenson, K. K., Ye, L., Coady, J. L., Wang, J. B., Wu, Y., et al. (2005). Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin- DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, people's republic of China. Cancer Epidemiol. Biomarkers Prev. 14, 2605-2613.
20. Kensler, T. W., Egner, P. A., Davidson, N. E., Roebuck, B. D., Pikul, A., and Groopman, J. D. (1986). Modulation of aflatoxin metabolism, aflatoxin-N 7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res. 46, 3924-3931.
21. Kensler, T. W., Groopman, J. D., Eaton, D. L., Curphey, T. J., and Roebuck, B. D. (1992). Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 13, 95-100.
22. Kensler, T. W., Qian, G. S., Chen, J. G., and Groopman, J. D. (2003). Translational strategies for cancer prevention in liver. Nature Reviews 3, 321-329.
23. Kensler, T. W., Roebuck, B. D., Wogan, G. N., and Groopman, J. D. (2011). Aflatoxin: a 50 year odyssey of mechanistic and translational toxicology. Toxicol. Sci. 120(supp. 1), S28-S48.
24. Langouet, S., Furge, L. L., Kerriguy, N., Nakamura, K., Guillouzo, A., and Guengerich, F. P. (2000). Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Chem. Res. Toxicol. 13, 245-252.
25. Roebuck, B. D., Curphey, T. J., Li, Y., Baumgartner, K. J., Bodreddigari, S., Yan, J., Gange, S. J., Kensler, T. W., and Sutter, T. R. (2003). Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz. Carcinogenesis 24, 1919-1928.
26. Rogers, A. E., Kula, N. S., and Newberne, P. M. (1971). Absence of an effect of partial hepatectomy on aflatoxin B 1 carcinogenesis. Cancer Res. 31, 491-495.
27. Wogan, G. N., and Newberne, P. M. (1967). Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. Cancer Res. 27, 2370-2376.
28. Zhang, Y., Kensler, T. W., Cho, C. G., Posner, G. H., and Talalay, P. (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. U.S.A 91, 3147-3150.